Financhill
Back

Oramed Pharmaceuticals Vs. Aritzia Industry Stock Comparison

Sell
39

ORMP
Oramed Pharmaceuticals

Last Price:
2.34
Seasonality Move:
22.85%
Sell
40

ATZAF
Aritzia

Last Price:
32.69
Seasonality Move:
14.48%
Sell
39
Oramed Pharmaceuticals (ORMP) is a Sell

Is Oramed Pharmaceuticals a Buy, Sell or Hold?

  • The current Oramed Pharmaceuticals [ORMP] share price is $2.33. The Score for ORMP is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • ORMP is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
40
Aritzia (ATZAF) is a Sell

Is Aritzia a Buy, Sell or Hold?

  • The current Aritzia [ATZAF] share price is $33.13. The Score for ATZAF is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • ATZAF is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

ORMP Stock Price Chart

What is Oramed Pharmaceuticals's stock price today?

  • The Oramed Pharmaceuticals share price today is $2.33
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ORMP is experiencing slight buying pressure.

ATZAF Stock Price Chart

What is Aritzia's stock price today?

  • The Aritzia share price today is $33.13
    The current trend is relatively stagnant and ATZAF is experiencing slight buying pressure.

ORMP Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.01 Sell
Relative Strength Index (14 RSI): 46.77 Sell
Chaikin Money Flow: -8376 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.33 - 2.39) Sell
Bollinger Bands (100): (2.32 - 2.52) Sell

ATZAF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.72 Sell
Relative Strength Index (14 RSI): 51.58 Buy
Chaikin Money Flow: 485 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (30.46 - 34.6) Buy
Bollinger Bands (100): (30.22 - 35.52) Buy

ORMP Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 2.34 Sell
20-day SMA: 2.35 Sell
50-day SMA: 2.38 Sell
200-day SMA: 2.52 Sell
8-day EMA: 2.34 Sell
20-day EMA: 2.35 Sell
50-day EMA: 2.37 Sell
200-day EMA: 2.51 Sell

ATZAF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 31.85 Buy
20-day SMA: 31.82 Buy
50-day SMA: 34.06 Sell
200-day SMA: 29.54 Buy
8-day EMA: 31.74 Buy
20-day EMA: 32.3 Buy
50-day EMA: 33.02 Buy
200-day EMA: 30 Buy

Oramed Pharmaceuticals Earnings Growth & ORMP Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.38 per share, and a decrease next year of $0.43 per share.

Aritzia Earnings Growth & ATZAF Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.17 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.68 per share, and an increase next year of $0.57 per share.

Oramed Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Aritzia Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):